Standout Papers

The PI3K/Akt/mTOR pathway in lung cancer; oncogenic alterations, therapeutic opportunities, challenges, and a glance at t... 2022 2026 2023 2024124
  1. The PI3K/Akt/mTOR pathway in lung cancer; oncogenic alterations, therapeutic opportunities, challenges, and a glance at the application of nanoparticles (2022)
    Mohammad‐Javad Sanaei, Sara Razi et al. Translational Oncology

Immediate Impact

19 standout
Sub-graph 1 of 8

Citing Papers

Deciphering the performance of macrophages in tumour microenvironment: a call for precision immunotherapy
2024 Standout
Epigenetics-targeted drugs: current paradigms and future challenges
2024 Standout
2 intermediate papers

Works of Sara Razi being referenced

The role of tumor microenvironment on cancer stem cell fate in solid tumors
2023
Identification of FDA approved drugs against SARS-CoV-2 RNA dependent RNA polymerase (RdRp) and 3-chymotrypsin-like protease (3CLpro), drug repurposing approach
2021

Author Peers

Author Last Decade Papers Cites
Sara Razi 147 70 39 45 8 291
Shen-Jue Chen 90 42 37 35 13 245
R. Magesh 195 31 39 28 18 307
Marcin Pilarczyk 190 33 28 36 5 294
J. Javier Hernández 146 17 12 33 7 287
Natasha Sharma 170 48 28 49 8 311
Wayne R. Danter 134 40 45 151 13 328
Prisca Lo Surdo 245 33 15 24 12 321
Bonnie A. Graham 191 61 20 45 8 335
Wiebke Haeusgen 192 34 11 34 11 311
Mingkun Lu 215 41 19 23 16 321

All Works

Loading papers...

Rankless by CCL
2026